EGFR and colorectal carcinoma: They were then evaluated for their anti-proliferative activity against carefully selected three cell lines namely: colorectal carcinoma HCT-116, hepatocellular carcinoma HepG-2 and breast MCF-7 cancer cell lines in which EGFR is expressed27.